1 2 3 
Tuesday, January 25, 2022

48Hour Discovery Inc. (48HD), a biopharmaceutical company specializing in peptide-derived drug discovery announced today that the company has entered into a strategic research collaboration with Fusion Pharmaceuticals.

Tuesday, December 21, 2021

VaxAlta Inc., an animal health biotechnology company focused on the development of new vaccines who has entered into a licensing & collaboration agreement w/ Scandinavian Biopharma Holdings

Tuesday, December 14, 2021

Accreditation issued by the Canadian Association for Laboratory Accreditation (CALA) for the testing of cannabis and natural health products at its laboratories in Leduc, Alberta.

Tuesday, December 14, 2021

Targets high quality mRNA COVID-19 vaccine to low-to middle-income countries at affordable prices.

Friday, November 26, 2021

Attestation Is a Testament to Our Values and Commitment to Stakeholder Privacy

Friday, November 26, 2021

Building a Patient-Centered Community by Generating Meaningful Data, Enhancing Collaborations, and Accelerating Outcomes

Monday, November 15, 2021

With more than $1 billion in revenues generated by Alberta companies and over 12,000 jobs expected to stem from the industry, the province's life sciences ecosystem has demonstrated strong performance and continued positive momentum..

Monday, November 15, 2021

BioAlberta announced the recipients of its 2020 Achievement Awards in recognition of the outstanding contributions of the individuals and companies whose innovation and achievements have contributed to the growing success of Alberta's life sciences sector

Friday, October 29, 2021

Request to postpone decision on July 15, 2021 PMPRB Guidelines changes

Friday, October 15, 2021

Culture Biosciences, a San Francisco-based technology company enabling biotech firms to develop manufacturing processes in the cloud, selected Scispot as its exclusive platform to automate workflows.

Wednesday, September 29, 2021

This licence allows PBG to diversify its GMP-compliant manufacturing business through the addition of natural health products including nutraceuticals, herbal remedies, vitamins, minerals and other non-prescription over the counter therapeutics.

Wednesday, September 1, 2021

BioAlberta remains opposed to both the process and content of Health Canada's PMPRB draft regulation proposals since they were first published.

Tuesday, August 17, 2021

Dataffinity Health unveils new name, new brand, and ambitious strategic growth plan

Thursday, August 5, 2021

CanBiocin companion animal probiotic currently undergoing European Food Safety Authority (EFSA) review

Monday, July 19, 2021

The Standard Processing Licence allows PBG to process and/or sell cannabis/hemp derived ingredients including extracts, concentrate, and isolates to other licenced partners.

Monday, July 19, 2021

Psychedelic medicine is a rapidly growing area and could be potential breakthrough therapeutics globally for psychiatric conditions such as depression, post-traumatic stress disorder (PTSD) and addiction.

Monday, July 12, 2021

48Hour Discovery Inc and RayzeBio announce research collaboration to discover and develop novel peptide-based radiopharmaceuticals to treat cancer.

Wednesday, July 7, 2021

FREDsense Technologies Corp. announces the closing of a Convertible Debenture valued at $2.5 million from BDC Capital's Cleantech Practice.

Wednesday, May 19, 2021

As part of this partnership, HelaPlex will gain access to a white label digital operating platform powered by Scispot.

Tuesday, April 20, 2021

The company strives to empower entrepreneurs to start and virtually run their biotech startups from garages, coffee shops, dorm rooms, or anywhere else innovation is born.

Tuesday, April 20, 2021

MACH32 and Andau Medical announced today that the Aerosol Containment Tent (ACT) has been successfully adopted by University Health Network in Toronto, Ontario

Friday, April 16, 2021

Firm also announces strategic partnership with Ayming Canada to help businesses maximize funding

Monday, April 12, 2021

BioAlberta has joined the national call for more collaboration to create a better environment for the development of new vaccines, meds and other health technologies in Canada.

1 2 3